Clinical scenario: Renal transplant | Immunosuppression | Raised creatnin
A 12-year-old boy underwent a deceased-donor renal transplant 8 months ago for end-stage kidney disease due to congenital obstructive uropathy. His maintenance immunosuppression includes tacrolimus, mycophenolate mofetil, and prednisolone.
He presents for routine follow-up and feels well. Blood pressure is normal, and there is no fever or graft tenderness. Investigations show:
- Serum creatinine: 0.8 → 1.5 mg/dL over 6 weeks
- Urinalysis: Trace protein, no hematuria
- Urine culture: Sterile
- Doppler ultrasound: Normal graft perfusion; no hydronephrosis
- Tacrolimus trough: Therapeutic
The transplant physician suspects BK polyomavirus nephropathy.
What is the most appropriate initial management?
A. High-dose intravenous methylprednisolone
B. Increase tacrolimus dose to prevent rejection
C. Reduce immunosuppressive therapy
D. Start intravenous immunoglobulin immediately
E. Start valganciclovir
Correct answer & Explanation:
Correct Answer: C. Reduce immunosuppressive therapy
Explanation
BK polyomavirus nephropathy is an important cause of late graft dysfunction after renal transplantation, typically occurring within the first year. Reactivation of latent BK virus occurs because of excessive immunosuppression, particularly with tacrolimus and mycophenolate.
The typical presentation includes:
- Progressive rise in serum creatinine
- Sterile urine culture
- Minimal urinary abnormalities
- Normal Doppler ultrasound excluding vascular or obstructive causes
The diagnosis is supported by:
- Quantitative plasma BK viral PCR
- Urine decoy cells (screening)
- Renal biopsy demonstrating polyomavirus nephropathy when the diagnosis is uncertain or before major treatment changes.
The cornerstone of treatment is stepwise reduction of immunosuppression, usually by reducing or discontinuing mycophenolate first and/or lowering tacrolimus exposure while closely monitoring graft function and viral load.
Why the other options are incorrect
A. High-dose intravenous methylprednisolone
Appropriate for acute cellular rejection, but it may worsen BK viral replication if given without excluding BK nephropathy.
B. Increase tacrolimus dose to prevent rejection
Would further suppress immunity and accelerate BK viral replication, increasing the risk of graft loss.
D. Start intravenous immunoglobulin immediately
IVIG has been used in selected refractory cases but is not first-line therapy.
E. Start valganciclovir
Valganciclovir is active against cytomegalovirus (CMV) and has no proven efficacy against BK polyomavirus.
Key Learning Points
- BK virus nephropathy should be suspected in any renal transplant recipient with an unexplained rise in creatinine and sterile urine, particularly within the first post-transplant year.
- Plasma BK PCR is the preferred screening test for viremia.
- The first-line treatment is careful reduction of immunosuppression, not antiviral therapy or corticosteroids.
- Failure to recognize BK nephropathy may lead to irreversible graft fibrosis and graft loss, while treating it as rejection with steroids can significantly worsen the infection.
